Source:http://linkedlifedata.com/resource/pubmed/id/10078550
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1999-3-30
|
pubmed:abstractText |
Islet duodenal homeobox 1 (IDX-1/PF-1/STF-1/PDX-1), a homeodomain protein that transactivates the insulin promoter, has been shown by targeted gene ablation to be required for pancreatic development. After 90% pancreatectomy (Px), the adult pancreas regenerates in a process recapitulating embryonic development, starting with a burst of proliferation in the epithelium of the common pancreatic duct. In this model, IDX-1 mRNA was detected by semiquantitative reverse transcription-polymerase chain reaction in total RNA from isolated common pancreatic ducts at levels 10% of those of isolated islets. The IDX-1 mRNA levels were not significantly different for common pancreatic ducts of Px, sham Px, and unoperated rats and did not change with time after surgery. By immunoblot analysis, IDX-1 protein was only faintly detected in these ducts 1 and 7 days after Px or sham Px but was easily detected at 2 and 3 days after Px. Similarly, IDX-1 immunostaining was barely detectable in sham or unoperated ducts but was strong in ducts at 2-3 days after Px. The increase of IDX-1 immunostaining followed that of BrdU incorporation (proliferation). These results indicate a posttranscriptional regulation of the IDX-1 expression in ducts. In addition, islets isolated 3-7 d after Px showed higher IDX-1 protein expression than control islets. Thus, in pancreatic regeneration IDX-1 is upregulated in newly divided ductal cells as well as in islets. The timing of enhanced expression of IDX-1 implies that IDX-1 is not important in the initiation of regeneration but may be involved in the differentiation of ductal cells to beta-cells.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0012-1797
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
507-13
|
pubmed:dateRevised |
2011-6-1
|
pubmed:meshHeading |
pubmed-meshheading:10078550-Animals,
pubmed-meshheading:10078550-Cell Division,
pubmed-meshheading:10078550-Cells, Cultured,
pubmed-meshheading:10078550-Gene Expression Regulation,
pubmed-meshheading:10078550-Homeodomain Proteins,
pubmed-meshheading:10078550-Islets of Langerhans,
pubmed-meshheading:10078550-Pancreas,
pubmed-meshheading:10078550-Pancreatectomy,
pubmed-meshheading:10078550-Pancreatic Ducts,
pubmed-meshheading:10078550-RNA, Messenger,
pubmed-meshheading:10078550-Rats,
pubmed-meshheading:10078550-Rats, Sprague-Dawley,
pubmed-meshheading:10078550-Regeneration,
pubmed-meshheading:10078550-Time Factors,
pubmed-meshheading:10078550-Trans-Activators,
pubmed-meshheading:10078550-Transcription, Genetic
|
pubmed:year |
1999
|
pubmed:articleTitle |
The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration.
|
pubmed:affiliation |
E.P. Joslin Research Laboratories, Joslin Diabetes Center, and the Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|